Breast Tissue Markers Market (Product: Coil, Ribbon, Bowtie, Butterfly, U Shape, and Others; and Material: Non-biodegradable and Partially Biodegradable)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Breast Tissue Markers market size was valued at USD 2.9 billion in 2021 and is predicted to hit USD 5.14 billion by 2030 with a registered CAGR of 8.3% during the forecast period 2022 to 2030.

Breast tissue markers are commonly used in mammography diagnostic imaging. Typically, these are implanted just after a percutaneous biopsy under ultrasonic or stereotactic guidelines. On follow-up imaging, these can be extremely helpful in identifying relatively harmless regions or shrinking/treated malignant lesions. Breast tissue markers are now available in various shapes, compositions, and partially bio-absorbable components. Ribbon, coil, and wing markers with easily distinguishable appearances on mammograms are among the makers currently in use. New ultrasound-detectable markers are also available in the market. Breast tissue markers can be used to guide subsequent radiotherapy treatments with clips inserted prior to surgery (localization wire targets).

Report Scope of the Breast Tissue Markers Market

Increase in Demand for Biodegradable Breast Tissue Markers Driving Global Market

In a biopsy procedure, a metal clip with a 3 mm diameter is commonly used as a radio marker so that the lesion can be clearly identified on subsequent imaging inspection. A metal clip marker remains in the breast indefinitely. This is a significant disadvantage. Therefore, most women refuse to have a biopsy. This is exacerbated when a patient has had numerous breast biopsies and much more than a metal clip marker is implanted to differentiate abnormal lesions on a mammography. Furthermore, metal clips migrate away from the biopsy insertion site after deployment. Another disadvantage of metal markers is that they cause issues during MRI because of changes in the local magnetic field caused by the implants' ferromagnetic, paramagnetic, and diamagnetic properties. This could reduce MRI's sensitivity for breast cancer detection and treatment monitoring. Therefore, biodegradable breast tissue markers are being developed as implants in the breast biopsy market. These biodegradable breast biopsy markers have the potential to serve as visual markers for breast tumor growth regions for the required follow-up period, such as six months, before being completely eliminated from the body.

Breast Cancer Awareness and Screening Programs Fueling Global Market

Regional government authorities are launching breast cancer awareness and screening programs to reduce the mortality rates associated with breast cancer. Breast cancer therapeutics are becoming more effective in the treatment of the disease, with more than 90% survival probabilities, especially when the disease is detected early. According to the World Health Organization, around 2.3 million new cases of breast cancer and 685,000 deaths were recorded globally in 2020. Breast cancer has been diagnosed in 7.8 million women in the previous five years ending 2020, making it the world's most common cancer.

Initiation of breast cancer awareness campaigns by public organizations is expected to encourage breast cancer learning and breast cancer therapeutic applications. The National Breast Cancer Foundation launched ‘October as Breast Cancer Awareness Month,’ a campaign to increase awareness about the dangers of breast cancer. Such efforts are expected to encourage recently diagnosed breast cancer patients, thereby driving the global market.

Rise in Number of Breast Biopsy Procedures Offering Growth Opportunities to Market Players

Breast biopsies are typically used to diagnose breast cancer, but these can also be used to screen for other diseases discovered during a physical examination. Breast biopsies are commonly performed using fine needle aspiration biopsy, which is one of the least invasive procedures available. It also does not leave any scarring. A needle is inserted through the dermal tissue of the breast to remove tissue. Another technique, known as stereotactic needle biopsy in combination with a mammogram, guides this same biopsy with ultrasound radiation. The ultrasound tracker directs the needle to the chosen place in the breast during treatment. Stereotactic mammography is a method that employs images taken from different vantage points to identify the site of a malignant tumor in addition to the placement of the needle used to acquire a breast biopsy sample. Thus, breast marker is a small titanium or stainless steel marker the size of a sesame seed. Breast biopsy markers are used to pinpoint the location of the breast tissue removed during a biopsy procedure.

Application in Identifying and Marking Biopsy Area Bolstering Coil Segment

In terms of product, the global breast tissue markers market has been classified into coil, ribbon, bowtie, butterfly, bowtie, U shape, and others. Coil breast tissue markers are commonly used in partially biodegradable breast tissue markers. These breast tissue markers help a surgeon diagnose and operate more effectively by identifying and marking the biopsy area with a physical tag. Furthermore, mergers and acquisitions are projected to drive the coil segment in the near future. For instance, Mammotome announced the launch of a new product line of flexible HydroMARK Breast Biopsy Site Marker applicators designed to improve the clinician's user experience. The new applicator line expands compatibility with leading vacuum-assisted breast biopsy systems, bringing the HydroMARK markers to more customers in more clinical settings.

Increase in Usage of Non-biodegradable Markers Across Globe

Based on material, the global breast tissue markers market has been bifurcated into partially biodegradable and non-biodegradable. Non-biodegradable clips are made up of titanium, with no absorbable PVA polymer pellet or other materials. Titanium is widely used in breast tissue markers. The breast tissue markers market is focusing on end-user education and training. Several companies operating in the global market are providing their products at reasonable prices.

Availability of High-quality Care Bolstering Hospitals Segment

In terms of end-user, the global breast tissue markers market has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics. Increasing number of patients are seeking hospitals that provide patient-centered care. In other words, these hospitals establish a reputation of offering patients high-quality care, giving them a competitive edge over institutions that continue to rely on outdated practices. Overall decrease in hospital care expenses is also projected to drive the hospitals segment during the forecast period.

Regional Outlook of Global Breast Tissue Markers Market

North America accounted for major share of around 40.9% of the global breast tissue markers market in 2021. According to the breast tissue markers market forecast, the region is anticipated to dominate the global breast tissue markers market in the next few years owing to the presence of major players, established diagnostic & screening infrastructure, technological advancements, high patient awareness, and favorable reimbursement policies. The prevalence of breast cancer is rising in North America. This has increased the usage of advanced diagnostic techniques in the region. The market in North America is expected to be driven by expanding healthcare infrastructure and favorable reimbursement policies in the region. Increase in disposable income, rapid urbanization, improved health care infrastructure, and distribution and partnership strategies adopted by key players are also propelling the market in the region.

The breast tissue markers market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to the surge in incidence of breast cancer and adoption of advanced diagnostic techniques in the region. Furthermore, rise in healthcare infrastructure and improving reimbursement guidelines are likely to augment the market in Asia Pacific.

Key Developments in Global Breast Tissue Markers Market

• In December 2021, Roche released its most recent digital pathology algorithms based on artificial intelligence (AI) to help pathologists evaluate Ki-67, ER, and PR breast cancer markers. The decision to choose a patient's therapy could be affected by the laborious manual methods for quantification of breast cancer markers, which have reported significant interobserver variability.
• In 2021, Hologic, Inc., an innovative medical technology company primarily focused on improving women's health, announced the completion of the acquisition of SOMATEX Medical Technologies GmbH for around US$ 64 Mn. E-Med Solutions GmbH, a group of investors led by Westlake Partners, a Germany-based private equity firm, previously owned the company.

Some of the prominent players in the Breast Tissue Markers Market include:

• Mammotome
• BD
• Hologic, Inc.
• Carbon Medical Technologies, Inc.
• Scion Medical Technologies, LLC
• Mermaid Medical
• SOMATEX Medical Technologies GmbH

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Breast Tissue Markers market

• Product
• Coil
• Ribbon
• Bowtie
• Butterfly
• U Shape
• Others
• Material
• Non-biodegradable
• Partially Biodegradable
• End-user
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Specialty Clinics

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Breast Tissue Markers industry analysis from 2022 to 2030 to identify the prevailing Breast Tissue Markers industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Breast Tissue Markers industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Breast Tissue Markers industry trends, key players, market segments, application areas, and market growth strategies.